Tofidence

Active Ingredient(s): Tocilizumab-bavi
FDA Approved: * September 29, 2023
Pharm Company: * BIOGEN MA

Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tofidence 20 mg/ml Intravenous Injection
NDC: 64406-022
Labeler:
Biogen Inc.
Tofidence 20 mg/ml Intravenous Injection
NDC: 64406-023
Labeler:
Biogen Inc.
Tofidence 20 mg/ml Intravenous Injection
NDC: 64406-024
Labeler:
Biogen Inc.

Related Brands

Drugs with the same active ingredients